Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2004 Apr 5;14(7):1721-7.

Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators.

Author information

1
Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-3500, USA. steve.elmore@abbott.com

Abstract

The SAR at C-5 of the 10-methoxy-2,2,4-trimethylbenzopyrano[3,4-f]quinoline core leading to identification of (-) anti 1-methylcyclohexen-3-yl as the optimum substituent that imparts minimal GR mediated in vitro transcriptional activation while maintaining full transcriptional repression is described. The in vitro profile of these candidates in human cell assays relevant to the therapeutic window of glucocorticoid modulators is outlined.

PMID:
15026058
DOI:
10.1016/j.bmcl.2004.01.044
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center